Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000879407-26-000020
Filing Date
2026-01-27
Accepted
2026-01-26 17:33:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A noiticeandfilingtext.htm DEFA14A 3811
2 GRAPHIC noiticeandfilingtext001.jpg GRAPHIC 61278
3 GRAPHIC noiticeandfilingtext002.jpg GRAPHIC 154286
4 GRAPHIC noiticeandfilingtext003.jpg GRAPHIC 122810
  Complete submission text file 0000879407-26-000020.txt   471406
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 26561495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)